Oragenics (OGEN) EPS (Diluted) (2022 - 2026)
Powered by 
Analysis
Oragenics (OGEN) EPS (Diluted) (2022 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn | 2.27 |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn | 2.04 |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn | -0.54 |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn | 1.67 |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | -0.04 |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn | 0.33 |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - | -3.06 |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn | 2.81 |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn | 7.27 |
| 10 | Oragenics | 2.24 Mn | 2.24 Mn | - | -0.57 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.57 |
| Mar 31, 2026 | -0.51 |
| Dec 31, 2025 | -1.12 |
| Sep 30, 2025 | -1.96 |
| Jun 30, 2025 | -3.10 |
| Mar 31, 2025 | -3.65 |
| Dec 31, 2024 | -15.30 |
| Sep 30, 2024 | -11.32 |
| Jun 30, 2024 | -15.27 |
| Mar 31, 2024 | -21.03 |
| Dec 31, 2023 | -170.01 |
| Sep 30, 2023 | -25.63 |
| Jun 30, 2023 | -45.20 |
| Mar 31, 2023 | -38.71 |
| Dec 31, 2022 | -33.42 |
| Sep 30, 2022 | -59.68 |
| Jun 30, 2022 | -55.52 |